Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;37(5):484-491.
doi: 10.1055/s-0040-1719189. Epub 2020 Dec 11.

Interventional Oncology Approach to Hepatic Metastases

Cathal O'Leary  1 , Michael C Soulen  1 , Susan Shamimi-Noori  1
Affiliations
Review

Interventional Oncology Approach to Hepatic Metastases

Cathal O'Leary et al. Semin Intervent Radiol. 2020 Dec.

Abstract

Metastatic liver disease is one of the major causes of cancer-related morbidity and mortality. Locoregional therapies offered by interventional oncologists alleviate cancer-related morbidity and in some cases improve survival. Locoregional therapies are often palliative in nature but occasionally can be used with curative intent. This review will discuss important factors to consider prior to palliative and curative intent treatment of metastatic liver disease with locoregional therapy. These factors include those specific to the tumor, liver function, liver reserve, differences between treatment modalities, and patient-specific considerations.

Keywords: ablation; hepatic metastases; liver reserve; locoregional therapy; transarterial therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Michael Soulen: Research Grants: Guerbet, Boston Scientific, Sirtex, Consultant: Guerbet, Genentech, Instylla. Susan Shamimi-Noori: Consultant: Boston Scientific, Sirtex.

References

    1. Benson A B, Al-Hawary M M, Arain M A. NCCN Guidelines Version 4.2020 Colon Cancer Continue NCCN Guidelines Panel Disclosures. 2020.
    1. Cummings M C, Simpson P T, Reid L E. Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol. 2014;232(01):23–31. - PMC - PubMed
    1. Field K M, Dow C, Michael M. Part I: Liver function in oncology: biochemistry and beyond. Lancet Oncol. 2008;9(11):1092–1101. - PubMed
    1. Mouli S K, Gupta R, Sheth N, Gordon A C, Lewandowski R J. Locoregional therapies for the treatment of hepatic metastases from breast and gynecologic cancers. Semin Intervent Radiol. 2018;35(01):29–34. - PMC - PubMed
    1. Benson A B, Abbott D E, Abrams T A. 2019. NCCN Guidelines Version 3. Hepatobiliary Cancers. - PubMed